The FDA has approved Tonmya (cyclobenzaprine hydrochloride sublingual tablets) for the treatment of fibromyalgia in adults.

A plan for tapering opioids should be developed to minimize withdrawal symptoms in children receiving opioids for 5 or more days.

Living in historically redlined areas is associated with a lack of rapid access to emergency medical services.